Glucophage

DMF filings hit all-time high in Q3 2024; China tops list with 58% increase in Type II submissions

Drug Master Files, or DMFs, are confidential documents that play a crucial role in the pharmaceutica

Endocrinology Newsmakers: Drugmakers work on triple agonist treatments, gene therapies to fight diabetes

Endocrinology, a medicinal branch that deals with endocrine and metabolic disorders, is witnessing

America’s drug price hike conundrum in backdrop of 2019 Medicare Part D data

Nearly every year, drugmakers ring in the new year with drug price increases in the US. This year

Top drugs and pharmaceutical companies of 2019 by revenues

Acquisitions and spin-offs dominated headlines in 2019 and the tone was set very early with Bristol-

COVID-19: India restricts drug exports amid rising prices of essential bulk drugs; FDA announces first drug shortage

Now that it has been established that the novel coronavirus is going to globally impact the drug s

Analyzing over US$ 90 billion of Medicare Prescription Drug (Part D) Spending in 2016

This week, PharmaCompass reviews the recently released data on prescription drugs paid for under th

Ghosts of GSK’s billion dollar mistake return; New date for electronic submissions of DMFs

This week, Phispers tells us why David Hung’s taking charge as CEO of Axovant could signal the

EU suspends drugs from Granules’ Indian facility where FDA had no concerns

In October 2016, the US Food and Drug Administration (FDA) inspected a facility in India belonging t

Drug costs and prescription trends in the United States: Analyzing Medicare’s $121 billion spend

In less than three weeks, Donald Trump will assume office as the President of the United States. He

FDA uncovers systemic data manipulation in China; India’s pharma lobby rubbishes report on pollution

This week, Phispers brings you news about Wockhardt and how its turnaround plans are going awry. The